Cargando…
Bortezomib-Induced Reversible Cardiomyopathy: Recovered With Guideline-Directed Medical Therapy
Bortezomib (BTZ) is a proteasome inhibitor (PI) used for the treatment of several hematologic malignancies, including multiple myeloma (MM), and various lymphomas including mantle cell lymphoma (MCL). It acts via disruption of the ubiquitin-proteasome pathway which plays a major role in regulating c...
Autores principales: | Sundaravel, Swethika H, Marar, Rosalyn I, Abbasi, Muhannad A, Baljevic, Muhamed, Stone, Jeremy R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742456/ https://www.ncbi.nlm.nih.gov/pubmed/35024253 http://dx.doi.org/10.7759/cureus.20295 |
Ejemplares similares
-
FOLFOX Induced Takotsubo Cardiomyopathy Treated with Impella Assist Device
por: Sundaravel, Swethika, et al.
Publicado: (2017) -
Bortezomib-Induced Perimyocarditis in a Multiple Myeloma Patient: A Case Report
por: Alali, Yaman, et al.
Publicado: (2021) -
Bortezomib Plus Melphalan-Induced Cardiomyopathy Presenting as Sinus Tachycardia and Systolic Heart Failure
por: Sampat, Parth J, et al.
Publicado: (2020) -
A Common Cardiac Tumor Revealed on Multimodality Imaging
por: Marar, Rosalyn Isam, et al.
Publicado: (2023) -
Reverse Takotsubo Cardiomyopathy in the Setting of Acute Asthma Exacerbation
por: Khan, Muhammad A, et al.
Publicado: (2021)